Skip to main content
Equibles

Candriam S.C.A.

Position in ALLO — Allogene Therapeutics, Inc.

CIK 1537014 STRASSEN, N4
Back to ALLO Full portfolio

Position in ALLO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$9,019,495
+$1,706,040 QoQ
Shares Held
4,336,296
+44.7% QoQ
Ownership
1.26%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#23
of 209 holders
Holding Since
Jun 2020
5 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALLO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Candriam S.C.A. holds $2,107,868,027 across 75 Biotechnology names. ALLO ranks #61 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 195,674 $122,010,565
2 RVMD
Revolution Medicines, Inc.
 556,392 $104,201,093
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 199,505 $99,100,118
4 ALNY
Alnylam Pharmaceuticals, Inc.
 314,512 $94,677,547
5 ONC
BeOne Medicines Ltd.
 289,735 $82,565,782
6 COGT
Cogent Biosciences, Inc.
 2,088,369 $80,819,880
7 ARGX
Argenx SE
 80,120 $74,332,932
8 ROIV
Roivant Sciences Ltd.
 1,990,510 $70,444,148

All Filings in ALLO

Export CSV
5 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,019,495 4,336,296
2026-03-31 $7,313,455 2,997,318
2025-12-31 $3,158,732 2,305,644
2020-09-30 $2,510,015 66,561
2020-06-30 $2,908,633 67,927